367 related articles for article (PubMed ID: 25449861)
21. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
Ammar G; Naja WJ; Pelissolo A
Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
[TBL] [Abstract][Full Text] [Related]
22. Antidepressants for smoking cessation.
Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
[TBL] [Abstract][Full Text] [Related]
23. Suicidality in pediatric patients treated with antidepressant drugs.
Hammad TA; Laughren T; Racoosin J
Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440
[TBL] [Abstract][Full Text] [Related]
24. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
26. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
27. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
28. Vortioxetine for depression in adults.
Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
[TBL] [Abstract][Full Text] [Related]
29. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
Thorkelson G; Bielefeldt K; Szigethy E
Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
[TBL] [Abstract][Full Text] [Related]
30. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.
Gomez AF; Barthel AL; Hofmann SG
Expert Opin Pharmacother; 2018 Jun; 19(8):883-894. PubMed ID: 29806492
[TBL] [Abstract][Full Text] [Related]
31. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E
MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113
[TBL] [Abstract][Full Text] [Related]
32. Pharmacotherapy for social anxiety disorder (SAnD).
Williams T; Hattingh CJ; Kariuki CM; Tromp SA; van Balkom AJ; Ipser JC; Stein DJ
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001206. PubMed ID: 29048739
[TBL] [Abstract][Full Text] [Related]
33. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
[TBL] [Abstract][Full Text] [Related]
34. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
Strawn JR; Prakash A; Zhang Q; Pangallo BA; Stroud CE; Cai N; Findling RL
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):283-93. PubMed ID: 25791145
[TBL] [Abstract][Full Text] [Related]
35. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
[TBL] [Abstract][Full Text] [Related]
36. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
37. Antidepressant treatment for postnatal depression.
Brown JVE; Wilson CA; Ayre K; Robertson L; South E; Molyneaux E; Trevillion K; Howard LM; Khalifeh H
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013560. PubMed ID: 33580709
[TBL] [Abstract][Full Text] [Related]
38. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
Morrison J; Schwartz TL
Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials.
Barth M; Kriston L; Klostermann S; Barbui C; Cipriani A; Linde K
Br J Psychiatry; 2016 Feb; 208(2):114-9. PubMed ID: 26834168
[TBL] [Abstract][Full Text] [Related]
40. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Mead GE; Hsieh CF; Lee R; Kutlubaev MA; Claxton A; Hankey GJ; Hackett ML
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD009286. PubMed ID: 23152272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
